Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.2 added and v3.5.0 removed.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedReplaced the Italy location entry from Padua to Padova (postal code 35128). The Padua listing was removed and the Padova listing added.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision information updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check40 days agoChange DetectedNo additions or deletions detected; the page content and structure appear unchanged.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1 as a metadata update; no study data or core content is affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.